Search

We aimed to examine the rate and characteristics of retracted articles in infectious diseases and clinical microbiology. Using the Retraction Watch Database, we conducted a cross-sectional study for retracted publications categorized as 'Infectious Disease' or 'Microbiology' until June 30 2022. We included publications for which citation information was available through the Web of Science database. Study characteristics, retraction trends and number of citations before and after the retraction year were analysed. Overall, 1004 retracted publications were included, retracted between August 1968 and June 2022. The number of retractions climbed through the years, peaking in 2020–2021. A total of 614 retractions originated from USA, China, and India, of total 183 736 PubMed publications from these countries. Overall, 378 (38%) were retracted because of errors; 182 (18%) because of plagiarism; and 142 (14%) because of falsification/fabrication. Specific reasons included 'concerns/issues about data' (158, 16%); 'duplication of image' (127, 13%); and 'unreliable results' (116, 12%). Of the 347 retractions during 2020 to June 2022, 91 (26%) were COVID-19 related. Fifty of 895 (5.6%) first authors had two retracted papers, and 14 (1.6%) had ≥2 retractions. Of 824 publications cited at least once, 466 (57%) were cited more often after retraction. Retractions of infectious diseases and clinical microbiology publications are increasing. Concerning reasons such as plagiarism, falsification/fabrication and errors are not uncommon. Nonetheless, these publications continue to be commonly cited after being retracted. [ABSTRACT FROM AUTHOR]

Access to medicines has become a major concern for countries worldwide during the COVID-19 pandemic, as pharmaceutical production and trade have been disrupted in the course of the crisis. Antibiotics are one group of medicines where worries about access have been raised. Access to the right antibiotic at the right time is important not only for curing infections of individual patients, but also for curbing antibiotic resistance globally. Reliable pharmaceutical supply is key to ensuring access to medicines. The global supply of generic medicines has over the last decades been transformed by the rise of India's pharmaceutical industry. In this paper, I trace the changing role of this industry for the global export of antibiotics, by mapping and describing changes in Indian antibiotic exports and discussing these in light of historical processes and events. The paper offers a novel approach to analyse global antibiotic trajectories by using international trade data from publicly available resources combined with a secondary literature review. I show that India's pharmaceutical industry today holds a key role as one of the world's biggest exporters of antibiotic medicines, but with an increasing dependency on China as a supplier of antibiotic ingredients. This produces both opportunities and concerns for access to antibiotics globally. • Offers a novel approach to trace antibiotic and pharmaceutical geographies. • Uses international trade data to map India's role for global antibiotics supply. • Describes that India has become one of the world's biggest exporters of antibiotics. • Shows that India is highly dependent on China for import of antibiotic ingredients. [ABSTRACT FROM AUTHOR]

The COVID-19 outbreak has led to a substantial loss of human life throughout the world and has a tremendous impact on healthcare services. Industry 4.0 technologies have established effective supply chain management towards the fulfillment of customized demands in the healthcare field. In addition, the internet of things, artificial intelligence, big data analytics, and 3D printing have been extensively used to combat the COVID-19 pandemic and assist in providing value-added services in the healthcare sector. Henceforth, this paper presents a scientometric analysis on the literature of aforementioned Industry 4.0 technologies in the context of COVID-19. It provides extensive insights into co-citation and co-occurrence analysis of high cited publications, participating countries, influential authors, prolific journals, and keywords using the CiteSpace tool. The analyses reveal that China has produced the highest research outputs, although India is the most collaborative country in this field. The current research hotspots include supply chain, 4D printing, and social distancing technologies. Furthermore, it explores emerging trends, intellectual structure of publications, research frontiers, and potential research directions for further work in the Industry 4.0 assisted healthcare domain. [Display omitted] • Industry 4.0 technologies have emerged in the healthcare domain as an area of growing interest in academia and industry discipline. • Artificial intelligence, big data analytics, internet of things and 3D printing have been extensively used to control the COVID-19 spread and assist in providing value-added services in the healthcare sector. • It explores emerging trends, intellectual structure of publications, and potential research directions for further work in the Industry 4.0 assisted healthcare domain. [ABSTRACT FROM AUTHOR]